Yu Meng

985 total citations
40 papers, 543 citations indexed

About

Yu Meng is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Yu Meng has authored 40 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Surgery and 8 papers in Oncology. Recurrent topics in Yu Meng's work include Endometrial and Cervical Cancer Treatments (5 papers), Ferroptosis and cancer prognosis (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Yu Meng is often cited by papers focused on Endometrial and Cervical Cancer Treatments (5 papers), Ferroptosis and cancer prognosis (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Yu Meng collaborates with scholars based in China, Canada and United States. Yu Meng's co-authors include Yingzi Ming, Mouze Liu, Wei Zhang, Zheng Yang, Mei Mei, Guangtong Deng, Furong Zeng, Quan Zhuang, Xiang Chen and Huiyan Sun and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neuroscience and Journal of Hepatology.

In The Last Decade

Yu Meng

36 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Meng China 13 155 134 90 86 77 40 543
Nithya Krishnan United States 16 232 1.5× 149 1.1× 108 1.2× 40 0.5× 64 0.8× 43 695
Elena Guillén‐Gómez Spain 14 163 1.1× 65 0.5× 70 0.8× 26 0.3× 42 0.5× 17 493
Joshua Yang United States 15 174 1.1× 273 2.0× 244 2.7× 36 0.4× 49 0.6× 49 829
Miriam C. Banas Germany 14 203 1.3× 178 1.3× 145 1.6× 43 0.5× 54 0.7× 32 807
Basset El Essawy United States 12 171 1.1× 200 1.5× 95 1.1× 183 2.1× 25 0.3× 17 781
Kazunori Inoue United States 14 255 1.6× 89 0.7× 20 0.2× 35 0.4× 62 0.8× 22 860
Graziano Oldani Switzerland 14 117 0.8× 348 2.6× 38 0.4× 105 1.2× 30 0.4× 51 731
Silvia Berra Italy 10 178 1.1× 60 0.4× 22 0.2× 19 0.2× 56 0.7× 21 529
Koei Yamada Japan 10 168 1.1× 66 0.5× 39 0.4× 56 0.7× 23 0.3× 10 630
Samuel Mon-Wei Yu United States 15 357 2.3× 172 1.3× 54 0.6× 72 0.8× 55 0.7× 34 830

Countries citing papers authored by Yu Meng

Since Specialization
Citations

This map shows the geographic impact of Yu Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Meng more than expected).

Fields of papers citing papers by Yu Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Meng. The network helps show where Yu Meng may publish in the future.

Co-authorship network of co-authors of Yu Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Meng. A scholar is included among the top collaborators of Yu Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Meng. Yu Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Li, Yu Meng, Ming Yang, & Jingqi Yang. (2025). The association of systemic immune-inflammation index with incident breast cancer and all-cause mortality: evidence from a large population-based study. Frontiers in Immunology. 16. 1528690–1528690. 4 indexed citations
2.
Meng, Yu, Man Wang, Fang Chen, et al.. (2025). An immortalized cochlear spiral ganglion neuronal cell line: a promising tool for hearing loss study. Neuroscience. 581. 256–268.
3.
Wang, Man, Yuechen Han, Xue Wang, et al.. (2025). Wnt signalling facilitates neuronal differentiation of cochlear Frizzled10-positive cells in mouse cochlea via glypican 6 modulation. Cell Communication and Signaling. 23(1). 50–50. 3 indexed citations
4.
Wang, Man, Yu Meng, Xue Wang, et al.. (2024). Current advances in biomaterials for inner ear cell regeneration. Frontiers in Neuroscience. 17. 1334162–1334162. 5 indexed citations
5.
Sun, Yuming, et al.. (2024). The prevalence, complications, and risk factors for infantile hemangioma: a systematic review and meta‐analysis. International Journal of Dermatology. 63(6). 737–746. 8 indexed citations
6.
Sun, Huiyan, Yu Meng, Lei Yao, et al.. (2024). Ubiquitin‐specific protease 22 controls melanoma metastasis and vulnerability to ferroptosis through targeting SIRT1/PTEN/PI3K signaling. SHILAP Revista de lepidopterología. 5(8). e684–e684. 6 indexed citations
7.
Le, Jiayuan, Yu Meng, Ying Wang, et al.. (2024). Molecular and therapeutic landscape of ferroptosis in skin diseases. Chinese Medical Journal. 137(15). 1777–1789. 8 indexed citations
8.
Xu, Dihui, Yu Meng, Xinyi Tang, et al.. (2024). Discovery of toad-derived peptide analogue targeting ARF6 to induce immunogenic cell death for immunotherapy of hepatocellular carcinoma. Journal of Pharmaceutical Analysis. 15(3). 101038–101038.
9.
Wu, Bing, et al.. (2023). Transportation of wind-smoke flow in full-scale laneway fire experiments. Fire Safety Journal. 142. 104038–104038.
11.
Yang, Zheng, et al.. (2022). GLP-1 receptor agonist-associated tumor adverse events: A real-world study from 2004 to 2021 based on FAERS. Frontiers in Pharmacology. 13. 925377–925377. 77 indexed citations
12.
Meng, Yu, Lihua Huang, Min Kong, et al.. (2021). The Expression and Role of microRNA-133a in Plasma of Patients with Kawasaki Disease. Immunological Investigations. 51(4). 826–838. 8 indexed citations
13.
Zhang, Fenfen, et al.. (2021). Diagnostic Value of Preoperative CA125, LDH and HE4 for Leiomyosarcoma of the Female Reproductive System. Cancer Management and Research. Volume 13. 4657–4664. 9 indexed citations
14.
Yang, Zheng, et al.. (2021). The association between GLP-1 receptor agonist and diabetic ketoacidosis in the FDA adverse event reporting system. Nutrition Metabolism and Cardiovascular Diseases. 32(2). 504–510. 27 indexed citations
15.
Meng, Yu, et al.. (2020). Association of MnSOD gene polymorphism with susceptibility to Kawasaki disease in Chinese children. Cardiology in the Young. 31(2). 179–185. 9 indexed citations
16.
Meng, Yu, Jian Liu, Ke Wang, et al.. (2020). Genome-wide association study identifies TPH2 variant as a novel locus for severe CV-A6-associated hand, foot, and mouth disease in Han Chinese. International Journal of Infectious Diseases. 98. 268–274. 2 indexed citations
17.
Liu, Xuefeng, Zhiqiang Chen, Yu Meng, et al.. (2019). Safety of Simultaneous Hepatectomy and Splenectomy in the Treatment of Hepatocellular Carcinoma Complicated with Hypersplenism: A Meta-analysis. Gastroenterology Research and Practice. 2019. 1–17. 10 indexed citations
18.
Cui, Jianfeng, Shiyu Wang, Ning Zhang, et al.. (2017). Preoperative prognostic nutritional index and nomogram predicting recurrence-free survival in patients with primary non-muscle-invasive bladder cancer without carcinoma in situ. OncoTargets and Therapy. Volume 10. 5541–5550. 13 indexed citations
19.
Wang, Shuanglian, Allen L. Feng, Tao Li, et al.. (2014). Ethanol induced impairment of glucose metabolism involves alterations of GABAergic signaling in pancreatic β-cells. Toxicology. 326. 44–52. 27 indexed citations
20.
Gong, Liang, Yanghua Tian, Huaidong Cheng, et al.. (2010). Conceptual implicit memory impaired in amnestic mild cognitive impairment patient. Neuroscience Letters. 484(2). 153–156. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026